Диссертация (1174217), страница 30
Текст из файла (страница 30)
70. – N. 5. — P. 257-265.184168. Hanna, B. Xanthomatous hypophysitis. / B. Hanna, Y.M. Li, T. Beutler, [et al.] // JClin Neurosci. – 2015. – Vol. 22. – N. 7. – P. 1091-1097.169. Hansen, K.R. Ovarian primordial and nongrowing follicle counts according to theStages of Reproductive Aging Workshop (STRAW) staging system. / Hansen K.R.,Craig L.B., Zavy M.T., [et al.] // Menopause. – 2012. – Vol. 19. – N. 2. – P. 164-171.170.
Hapgood, J.P. Potency of progestogens used in hormonal therapy: towardunderstanding differential actions. / J.P. Hapgood, D. Africander, R. Louw, [et al.]// J Steroid Biochem Mol Biol. – 2014. – Vol. 142. – P. 39-47.171. Harlow, S.D. Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive ageing. /S.D.
Harlow, M. Gass, J.E. Hall, [et al.]; STRAW+10 Collaborative Group. // J ClinEndocrinol Metab. – 2012. – Vol. 97. – N. 4. – P. 1159-1168.172. Harlow, S.D. Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive ageing. / S.D.Harlow, M. Gass, J.E. Hall, [et al.]; STRAW+10 Collaborative Group. //Climacteric. – 2012. – Vol. 15. – N. 2. – P. 105-114.173. Harman, D. Aging: a theory based on free radical and radiation chemistry / D.Harman.
// Journal of gerontology. – 1956. – Vol. 11. – N. 3. – P. 298-300., 58174. Harman, D. Origin and evolution of the free radical theory of aging: a brief personalhistory, 1954–2009. / D. Harman. // Biogerontology. – 2009. – Vol. 10. – N. 6. –P. 773-781.175. Harman, D. The biologic clock: the mitochondria? / D. Harman // J Am GeriatrSoc. – 1972. – Vol. 20. – N. 4. – P. 145-147.176. Hayflick, L.
The serial cultivation of human diploid cell strains / L. Hayflick, P.S.Moorhead. // Exp Cell Res. – 1961. – Vol. 253. – P. 585-621.177. Hays, J. Effects of estrogen plus progestin on health-related quality of life. / J. Hays,J.K. Ockene, R.L. Brunner RL, [et al.] // N Engl J Med. – 2003. – Vol. 348. –P. 1839-1854.178. Heikkinen, J. A 10-year follow-up of postmenopausal women on long-termcontinuous combined hormone replacement therapy: Update of safety and quality-185of-life findings.
/ J. Heikkinen, R. Vaheri, U. Timonen. // J Br Menopause Soc. –2006. – Vol. 12. – N. 3. – P. 115-125.179. Hellgren, M. Cardiovascular risk markers during treatment with estradiol andtrimegestone or dydrogesterone. // M. Hellgren, J. Conard, L. Norris, C. Kluft. //Maturitas.
– 2009. – Vol. 62. – N. 3. – P. 287-293.180. Hertrampf, T. Estrogen receptor subtype-specific effects on markers of bonehomeostasis / T. Hertrampf, B. Schleipen, M. Velders, [et al.] // Mol CellEndocrinol. – 2008. – Vol. 291. – N. 1-2. – P.
104-108.181. Hewitt, S.C. Estrogen Receptors: New Directions in the New Millennium. / S.C.Hewitt, K.S. Korach. // Endocrine Reviews. – 2018. – Vol. 39. – N. 5. – P. 664-675.182. Hlatky, M.A. Quality-of-life and depressive symptoms in postmenopausal womenafter receiving hormone therapy: results from the Heart and Estrogen/ProgestinReplacement Study (HERS) trial. / M.A. Hlatky, D. Boothroyd, E.
Vittinghoff, [etal.]; Heart and Estrogen/Progestin Replacement Study (HERS) Research Group //JAMA. – 2002. – Vol. 287. – N. 5. – P. 591-597.183. Hu, L. Converse regulatory functions of estrogen receptor-alpha and -beta subtypesexpressed in hypothalamic gonadotropin-releasing hormone neurons / L. Hu, R.L.Gustofson, H. Feng, [et al.] // Mol Endocrinol. – 2008. – Vol. 22. – N. 10. –P. 2250-2259.184. Ilovayskaya, I.A.
Bone metabolism in young women with central hypogonadism issimilar or worse than in healthy postmenopausal women / I.A. Ilovayskaya, V.Y.Zektser, L.B. Lazebnik // Gynecol Endocrinol. – 2016. – Vol. 32. – Suppl. 1. – Р. 90.185. Ilovayskaya, I.A. Central hypogonadism in young women is assosiated withpremature ageing / I.A. Ilovayskaya, V.Y. Zektser, L.B. Lazebnik // GynecolEndocrinol. – 2016. – Vol.
32. – Suppl. 1. – P. 48.186. Ilovayskaya, I.A. Similarity of female central (hypogonadotropic) hypogonadismand postmenopause. / I.A. Ilovayskaya, V.Y. Zektser, L.B. Lazebnik. // Climacteric.– 2017. – Vol. 20. – N. 4. – P. 356-361.187. Ilovayskaya,I.A.Stagesofreproductiveagingandhypogonadotropichypogonadism: does "central menopause" exist? / I.A. Ilovayskaya, L.B. Lazebnik.// Climacteric. – 2016. – Vol. 19. – Suppl.
1. – Р. 43.186188. Ilovayskaya, I.A. STRAW+10 and hypogonadotropic hypogonadism: does "centralmenopause" exist? / I.A. Ilovayskaya, V.Y. Zektser, A.V. Dreval, L.B. Lazebnik //Proceedings of the 20th World Congress on Controversies in Obstetrics,Gynecology and Infertility. – 2015. – Р.
111-116.189. Ilovayskaya, I.A. Ultrasound characteristics of uterus and ovaries in women withhypogonadotropic hypogonadism before and after hormonal therapy / I.A.Ilovayskaya, V.Y. Zektser, N.A. Mazerkina, [et al.] // Gynecol Endocrinol. – 2016.– Vol. 32. – Suppl. 1. – Р. 93.190. Ilovayskaya, I.A. Evaluation of stage of reproductive ageing in women with central(hypogonadotropic) hypogonadism./ I.A. Ilovayskaya, L.B.Lazebnik.// Abstractbook of 16th World Congress on Menopause (electronic version).
– Vancouver(Canada), 6-9 June 2018. – ID7871.191. Ilovayskaya, I.A. Signs and biochemical markers of premature aging in women withcentral (hypogonadotropic) hypogonadism./ I.A. Ilovayskaya, L.B. Lazebnik.//Abstract book of 16th World Congress on Menopause (electronic version). –Vancouver (Canada), 6-9 June 2018. – ID7635.192.
Ilovayskaya, I.A. Fertility restoration in female patients with hypopituitarism. / I.A.Ilovayskaya, T.A. Nazarenko, Y.Z. Zaydieva, L.S. Logutova // Endocrine Abstracts.– 2018. – Vol. 56. – P933.193. Ilovayskaya, I.A. Women's health maintenance and anti-aging. / I.A. Ilovayskaya.// Congress book of the 16th Aesthetic and Anti-aging Medicine World Congress. –Monte-Carlo (Monako), 5-7 April 2018.
– P. 95.194. Iorga, A. The protective role of estrogen and estrogen receptors in cardiovasculardisease and the controversial use of estrogen therapy. / A. Iorga, C.M. Cunningham,S. Moazeni, [et al.] // Biol Sex Differ. – 2017. – Vol. 24. – N. 8 (1). – P. 33.195. Ishunina, T.A.
Transcriptional activity of human brain estrogen receptor-α splicevariants: evidence for cell type-specific regulation. / T.A. Ishunina, A.A. Sluiter,D.F. Swaab, R.W. Verwer // Brain Res. – 2013. – Vol. 1500. – P. 1-9.196. Iwasa, T. The roles of kisspeptin and gonadotropin inhibitory hormone in stressinduced reproductive disorders. / T. Iwasa, T. Matsuzaki, K.
Yano, [et al.] //Endocr J. – 2018. – Vol. 65. – N. 2. – P. 133-140.187197. Jäger, K. Therapeutic Targeting of Telomerase / K. Jäger, M. Walter // Genes(Basel). – 2016. – Vol. 7. – N. 7. – pii. E39.198. Javed, A. Female athlete triad and its components: toward improved screening andmanagement. / A. Javed, P.J. Tebben, P.R. Fischer, A.N. Lteif // Mayo Clin Proc. –2013. – Vol. 88. – N. 9. – P. 996-1009.199. Jia, M. Estrogen receptor alpha and beta in health and disease. / M.
Jia, K. DahlmanWright, J.Å. Gustafsson // Best Pract Res Clin Endocrinol Metab. – 2015. – Vol. 29.– N. 4. – P. 557-568.200. Jiménez-Jiménez, F.J. An Update on the Role of Nitric Oxide in theNeurodegenerative Processes of Parkinson's Disease. / F.J. Jiménez-Jiménez, H.Alonso-Navarro, M.T. Herrero, [et al.] // Curr Med Chem.
– 2016. – Vol. 23. –P. 2666-2679.201. Kalantaridou,S.N.Corticotropin-releasinghormone,stressandhumanreproduction: an update. / S.N. Kalantaridou, E. Zoumakis, A. Makrigiannakis,[et al.] // J Reprod Immunol. – 2010. – Vol. 85. – N. 1. – P. 33-39.202. Kannel, W.B. Menopause and risk of cardiovascular disease. The FraminghamStudy. / W.B.
Kannel, M.C. Hjortland, P.M. McNamara, T. Gordon // Ann Int Med.– 1976. – Vol. 85. – P. 447-452.203. Karaca, Z. GH and Pituitary Hormone Alterations After Traumatic Brain Injury. /Z. Karaca, F. Tanrıverdi, K. Ünlühızarcı, F. Kelestimur // Prog Mol Biol Transl Sci.– 2016.
– Vol. 138. – P.167-191.204. Karaca, Z. Sheehan syndrome. / Z. Karaca Z, B.A. Laway, H.S. Dokmetas, [et al.]// Nat Rev Dis Primers. – 2016. – N. 2. – P. 16092.205. Karaca, Z. The management of hypophysitis. / Z. Karaca, F. Kelestimur // MinervaEndocrinol. – 2016. – Vol.
41. – N. 3. – P. 390-399.206. Karamouzis, I. Clinical and diagnostic approach to patients with hypopituitarismdue to traumatic brain injury, subarachnoid hemorrhage, and ischemic stroke. / I.Karamouzis, L. Pagano, F. Prodam, [et al.] // Endocrine. – 2016. – Vol. 52. – N. 3.– P. 441-450.207. Karavitaki, N. Management of craniopharyngiomas / N. Karavitaki // J EndocrinolInvest.
– 2014. – Vol. 37. – N. 3. – P. 219-228.188208. Karges, B. Clinical and molecular genetics of the human GnRH receptor. / B.Karges, W. Karges, N. de Roux // Hum Reprod Update. – 2003. – Vol. 9. – N. 6. –P. 523-530.209. Khan, U.I. Progression from metabolically benign to at-risk obesity inperimenopausal women: a longitudinal analysis of study of women across the nation(SWAN). / U.I. Khan, D. Wang, C.A. Karvonen-Gutierrez, [et al.] // J ClinEndocrinol Metab. – 2014. – Vol. 99. – N.
7. – P. 2516-2525.210. Khare, S. Primary (autoimmune) hypophysitis: a single centre experience. / S.Khare, V.S. Jagtap, S.R. Budyal, [et al.] // Pituitary. – 2015. – Vol. 18. – N. 1. –P. 16-22.211. Kilic, S. Effect of non-oral estrogen on risk markers for metabolic syndrome in earlysurgically menopausal women.
/ S. Kilic, N. Yilmaz, G. Erdogan, [et al.] //Climacteric. – 2010. – Vol. 13. – N. 1. – P. 55-62.212. Kilicli F. Sheehan's syndrome. / F. Kilicli, H.S. Dokmetas, F. Acibucu // GynecolEndocrinol. – 2013. – Vol. 29. – N. 4. – P. 292-295.213. Kim J.H. The role of estrogen in adipose tissue metabolism: insights into glucosehomeostasis regulation. / J.H.
Kim, H.T. Cho, Y.J. Kim.// Endocr J. – 2014. –Vol. 61. – N. 11. – P. 1055-1067.214. Kim, H.G. The role of CHD7 and the newly identified WDR11 gene in patients withidiopathic hypogonadotropic hypogonadism and Kallmann syndrome. / H.G. Kim,L.C. Layman // Mol Cell Endocrinol. – 2011. – Vol. 346.
– N. 1-2. – P. 74-83.215. Kim, H.J. Uterine Development After Estrogen Replacement Therapy in WomenwithDifferentEtiologiesofPrimaryHypogonadism./H.J. Kim, D.Y. Lee, B.К. Yoon, D. Choi.// J Pediatr Adolesc Gynecol. – 2016. –Vol. 29. – N. 4. – P. 344-7.216. Kim, T. Translational control of gene expression in the gonadotrope. / T. Kim,M.H.
Do, M.A. Lawson // Mol Cell Endocrinol. – 2014. – Vol. 385. – N. (1-2). –P. 78-87.217. Klose, M. Patient reported outcome in posttraumatic pituitary deficiency: resultsfrom The Danish National Study on posttraumatic hypopituitarism. / M. Klose, K.189Stochholm, J. Janukonyté [et al.] // Eur J Endocrinol. – 2015. Vol. 172.
– N. 6. –P. 753-762.218. Kolovou, G.D. Body mass index, lipid metabolism and estrogens: their impact oncoronary heart disease. / G.D. Kolovou, V. Kolovou, P.M. Kostakou, S. Mavrogeni// Curr Med Chem. – 2014. – Vol. 21. – P. 3455-3465.219. Korol, D.L. Estrogens and cognition: Friends or foes?; An evaluation of theopposing effects of estrogens on learning and memory.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
